Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer

scientific article published on 01 April 2001

Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11309336

P2093author name stringNakamura Y
Yoshimoto M
Emi M
Hirano A
Sakamoto G
Kasumi F
Haga S
Akiyama F
Kajiwara T
Tsuneizumi M
Utada Y
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)876-882
P577publication date2001-04-01
P1433published inClinical Cancer ResearchQ332253
P1476titleAllelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer
P478volume7

Reverse relations

cites work (P2860)
Q273403168p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis
Q64067402Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas
Q36694764Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential
Q33867526Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma
Q37524058CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations
Q36545056CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8.
Q33299319Changes in allelic imbalances in locally advanced breast cancers after chemotherapy
Q37464084Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA.
Q37712773Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer
Q38649909Impact of CYP2D6 polymorphisms on endoxifen concentrations and breast cancer outcomes.
Q36047387Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.
Q35056229Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy
Q34442167Molecular alterations associated with breast cancer mortality
Q24317675Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector family
Q37678053Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer
Q35810123Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature
Q28741460Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer
Q34668320The prognostic molecular markers in hepatocellular carcinoma
Q33910850Type II transmembrane serine protease gene variants associate with breast cancer
Q35244308p53 regulates the expression of human angiotensin II AT(2) receptor interacting protein (ATIP1) gene

Search more.